LOX and ischemic stroke: These findings suggest that both ACSL4 and LOX involved in lipid metabolism can serve as innovative therapeutic targets for ischemic stroke (Cui et al., 2021), inhibiting ferroptosis by reducing ROS accumulation and lipid peroxidation, providing new ideas for the treatment of ischemic stroke (Li et al., 2021).